Generic name:erdafitinib [ ER-da-FI-ti-nib ]
Drug class:Multikinase inhibitors
What is Balversa?
Balversa is used to treat bladder cancer that has spread to other parts of the body (metastatic), or cannot be removed with surgery.
Balversa is used only if your cancer has a specific genetic marker (an abnormal "FGFR" gene). Your doctor will test you for this gene.
Balversa is usually given after other treatments have failed.
Balversa was approved by the US Food and Drug Administration (FDA) on an "accelerated" basis. In clinical studies, some people responded to this medicine, but further studies are needed.
Warnings
Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.
Before taking this medicine
Balversa may affect fertility (ability to have children) in women. However, it is important to use birth control to prevent pregnancy because erdafitinib can harm an unborn baby.
You may need to have a negative pregnancy test before starting Balversa.
Tell your doctor if you have ever had problems with your eyes or vision.
Both men and women using this medicine should use effective birth control to prevent pregnancy. Erdafitinib can harm an unborn baby or cause birth defects if the mother or father is using this medicine.
Keep using birth control for at least 1 month after your last dose. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using Balversa.
How should I take Balversa?
Take Balversa exactly as prescribed by your doctor. Follow all directions on your prescription label...
